S

Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373

Watchlist Manager
Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373
Watchlist
Price: 6.04 CNY 1% Market Closed
Market Cap: 4B CNY

Wall Street
Price Targets

Price Targets Summary
Shanghai MicuRx Pharmaceutical Co Ltd

There are no price targets for Shanghai MicuRx Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shanghai MicuRx Pharmaceutical Co Ltd Competitors:
Price Targets
IMTX
Immatics NV
81% Upside
PHIL
Philogen SpA
15% Upside
NTLA
Intellia Therapeutics Inc
140% Upside
NRIX
Nurix Therapeutics Inc
57% Upside
MRNA
Moderna Inc
22% Upside
TRDA
Entrada Therapeutics Inc
67% Upside
ADAG
Adagene Inc
411% Upside
KMDA
Kamada Ltd
89% Upside

Revenue
Forecast

Revenue Estimate
Shanghai MicuRx Pharmaceutical Co Ltd

The compound annual growth rate of Shanghai MicuRx Pharmaceutical Co Ltd's revenue for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai MicuRx Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shanghai MicuRx Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai MicuRx Pharmaceutical Co Ltd's stock price target?
Not Available

Shanghai MicuRx Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shanghai MicuRx Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
24%

The compound annual growth rate of Shanghai MicuRx Pharmaceutical Co Ltd's revenue for the next 3 years is 24%.

Back to Top